Padcev (enfortumab vedotin-ejfv) is used for the treatment of patients with bladder and urinary tract cancer called urothelial carcinoma.

PADCEV is a Nectin-4-directed antibody and microtubule inhibitor conjugate indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor, and a platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced or metastatic setting.

Padcev (enfortumab vedotin-ejfv) suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of Padcev (enfortumab vedotin-ejfv) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Padcev enfortumab vedotin-ejfv medicine cost price in India.

The order for Padcev (enfortumab vedotin-ejfv) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

In December 2019, enfortumab vedotin-ejfv for injection was approved in the United States for the treatment of adult patients with locally advanced or metastatic urothelial cancer who had previously received a programmed cell death receptor-1 (PD-1) or programmed death ligand 1 (PD-L1) inhibitor and a platinum-containing chemotherapy.

PADCEV (enfortumab vedotin-ejfv) for injection, for intravenous use Initial U.S. Approval: 2019

Generic Name: enfortumab vedotin-ejfv for injection

For Injection: 20 mg and 30 mg of enfortumab vedotin-ejfv as a lyophilized powder in a single-dose vial for reconstitution

Padcev (enfortumab vedotin-ejfv)

GET IN TOUCH
with Indian Pharma Network

Indian Pharma Network, Delhi provides access to PADCEV enfortumab vedotin-ejfv for injection on the Named Patient Import basis in India.

Indian Pharma Network (IPN), Delhi. India

IPN, Delhi are legitimate consultant and facilitator in India, group of highly qualified pharma professionals. Specialized in Oncology and other pharma products. Helped more than 6,000 patients. Registration Number: 07AAFFI2544E1ZO under GST Act. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India. IPN, New Delhi helps patient to get access of anti cancer medicines which is not available in India.

BRANCH OFFICE : NEW DELHI | MUMBAI | BENGALURU | KOLKATA | LUCKNOW | JAIPUR | JODHPUR | PUNJAB | CHANDIGARH
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone

M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support

info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Padcev (enfortumab vedotin-ejfv)

News / Update for Padcev (enfortumab vedotin-ejfv) .

For Padcev (enfortumab vedotin-ejfv) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Astellas and Seattle Genetics Receive FDA Breakthrough Therapy Designation for PADCEV™ (enfortumab vedotin-ejfv) in Combination with Pembrolizumab in First-Line Advanced Bladder Cancer For More Details

Enfortumab Vedotin + Pembrolizumab Shrink Tumors in the Majority of Bladder Cancer Patients For More Details

Padcev (enfortumab vedotin-ejfv) manufacturer and suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Padcev (enfortumab vedotin-ejfv) on prescription and Import License in Patient's Name only.

For overseas patients, Padcev (enfortumab vedotin-ejfv) can be made available in Send your enquiry to find Padcev (enfortumab vedotin-ejfv) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

Steps to access Padcev (enfortumab vedotin-ejfv) on the Named Patient Import basis.

Step 1.
You send a request for your medicine online:-
Submit a request for a specific medicine, or a general request, and your Patient Support Manager will contact you within 24 hours. They will be there to support and guide you in anyway possible to help you get the medicine you need.

Step 2.
We verify your prescription and medical details:-
Since we help patients access medicines not available in their home country, our first step is to check that the medicine you need is not currently available in your home country. Next we will also verify that you have a prescription from a doctor in your home country for the medicine you need.

Step 3.
We source your medicine:-
Once we have verified your prescription and medical details, our expert sourcing team will work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.

Step 4.
We deliver your medicine:-
After you have accepted our offer, our experienced logistics team will arrange all the shipping and transportation of your medicine.

Documentation for Named-Patient import to access Padcev (enfortumab vedotin-ejfv).

Doctor’s Prescription –
We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.

Patient’s Medical history –
We would require all test reports and medical reports of the patient for last 3 months.

Patient’s Identity card –
We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

Room temperature shipping

For this medication, standard shipping applies. This means that a consistent room temperature of 15 to 25°C is maintained during transit.

Your order will be shipped to you by our partner couriers, such as DHL, UPS and specialised cold chain couriers. If you would like your order to be shipped by a specific courier, please inform us when you place the order. Our standard delivery time varies from 5 to 10 working days. The shipping cost depends on the medicine and the destination country. After making an enquiry, you will receive a detailed quote that includes the shipping costs.

IPN, Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified professionals of pharmaceutical Industry. Registration Number :07AAFFI2544E1ZO under GST Act. Specialized in Oncology Pharmacy. Helped more than 6,000 patients.

Helps you access to a FDA approved medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery.

Get Access To FDA Approved Drug PADCEV (enfortumab vedotin-ejfv) for injection In India

Indian Pharma Network (IPN), Delhi India is a leading Pharmaceutical Distributor / Supplier / Exporter / Importer of Anti-Cancer Medicines, used to treat urothelial cancer (bladder cancer). Brand Name "PADCEV (enfortumab vedotin-ejfv) for injection" or Generic Name "enfortumab vedotin-ejfv for injection" can be imported for personal use under "patient name basis" treatment in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India. Contact us at urgent@indianpharmanetwork.co.in or call/WhatsApp at +91 9891296838 / 9811747774 to get access as per norms.